Intensive care medicine department, at Saint Louis hospital, France.

Prof. Elie Azoulay is a distinguished French intensivist and the Director of the Critical Care Department at Hôpital Saint-Louis in Paris. He is renowned for his pioneering work in managing critically ill immunocompromised patients. As the founder and director of Nine-I, a multinational group focusing on immunocompromised patients, and co-director of the Famirea Study Group, he has significantly advanced research in intensive care medicine. His leadership extends to founding GRRR-OH, a French multicenter group dedicated to critically ill immunocompromised patients. Prof. Azoulay’s academic contributions are further highlighted by his role as Editor-in-Chief of Intensive Care Medicine from 2012 to 2018, during which the journal’s impact factor rose from 5 to 18. He has also served as President of the European Society of Intensive Care Medicine and is an advisory board member for The Lancet Respiratory Medicine.

Professional Profile

Scopus

ORCID

Google Scholar

🎓 Education

Prof. Azoulay’s academic journey began at Paris VI University (Sorbonne), where he earned his MD in 1991. He furthered his expertise with a Master’s degree in Respiratory Physiology from Paris XII University in 1995. In 2002, he completed his PhD in Respiratory Physiology at Paris VII University (Descartes). His commitment to advancing medical science led him to obtain Habilitation to Conduct and Lead Research from Paris VII University in 2003. Additionally, he holds a University Diploma in Critical Care Management of Immunocompromised Patients from Université Paris Cité, obtained in 2012. His educational background underscores his dedication to both clinical excellence and research innovation in intensive care medicine.

💼 Experience

Prof. Azoulay has an extensive career in intensive care medicine, beginning as a medical intern at Bichat-Claude Bernard Hospital in Paris. He has held significant positions, including serving as a professor of medicine at Paris VII University since 2004. His leadership roles encompass founding and directing several research groups, such as GRRR-OH and Nine-I, focusing on critically ill immunocompromised patients. He has been actively involved in various committees, including the Strategy Committee of the Hospital Group in Paris and the Medical Staffing Group. Prof. Azoulay’s editorial contributions are notable, having served as Editor-in-Chief of Intensive Care Medicine and as an associate editor for prominent journals like Critical Care Medicine and American Journal of Respiratory and Critical Care Medicine. His work has significantly influenced the field of intensive care medicine, particularly concerning immunocompromised patients.link.springer.com

🔬 Research Interests

Prof. Azoulay’s research primarily focuses on the management of critically ill immunocompromised patients, particularly those with hematological malignancies or undergoing immunosuppressive therapies. His work addresses acute respiratory failure, infections, and the psychosocial impact on patients and their families. He has led multicenter studies on the outcomes of intensive care in immunocompromised patients and the prevalence of ICU-related conflicts. His research also delves into the prevention of mental health disorders in ICU settings and the development of strategies to support family members of critically ill patients. Through his interdisciplinary approach, Prof. Azoulay aims to enhance patient care and outcomes in intensive care units.

🏆 Awards

Prof. Azoulay’s exceptional contributions to intensive care medicine have been recognized with several prestigious awards. In 2021, he received the International KJF Award, acknowledging his significant impact on critical care research. His editorial leadership has been instrumental in elevating the impact factor of Intensive Care Medicine. Additionally, his involvement in various international research initiatives has garnered him recognition from global medical communities. These accolades reflect his dedication to advancing the field of intensive care medicine and improving patient outcomes worldwide.rigshospitalet.dk

📚 Top Noted Publications

Prof. Azoulay has authored over 1,200 publications, contributing extensively to the field of intensive care medicine. Notable among his works is the 2019 study on acute respiratory failure in immunocompromised adults, published in The Lancet Respiratory Medicine, which has been cited over 1,000 times. His 2022 research in JAMA on post-traumatic stress symptoms in family members of ICU patients has also garnered significant attention. These publications reflect his commitment to addressing both clinical and psychosocial aspects of critical care. His work continues to influence practices and policies in intensive care units globally.

📌 1. Outcomes in Immunocompromised Patients with Acute Hypoxemic Respiratory Failure Treated by High-Flow Nasal Oxygen

Journal: Intensive Care Medicine
Date: April 2025
DOI: 10.1007/s00134-025-07890-5
Authors: Elie Azoulay, Mélanie Métais, Virginie Lemiale, Djamel Mokart, et al.
Summary:
This multicenter study evaluates the effectiveness and outcomes of high-flow nasal oxygen (HFNO) in immunocompromised patients with acute hypoxemic respiratory failure (AHRF). Key findings suggest that early initiation of HFNO is associated with improved survival, particularly in hematologic patients. It supports HFNO as a frontline noninvasive respiratory support strategy in this vulnerable population.

📌 2. Correction: HELLO – A Protocol for a Cluster RCT to Enhance ICU Team Cohesion

Journal: Intensive Care Medicine Experimental
Date: January 2025
DOI: 10.1186/s40635-024-00702-y
Authors: Elie Azoulay, Nancy Kentish Barnes, Sheila Nainan Myatra, et al.
Summary:
This correction addresses minor protocol amendments in the HELLO trial, aimed at improving interpersonal relationships and teamwork among ICU professionals. The original trial focuses on evaluating whether targeted interventions can reduce burnout and enhance job satisfaction, thus improving team-based care delivery.

📌 3. Lack of Up-to-Date Studies and Data Conversion May Lead to Biased Results: A Response to Wang et al.

Journal: Critical Care
Date: December 2024
DOI: 10.1186/s13054-024-05223-4
Authors: Ali Ait Hssain, Amir Vahedian-Azimi, Elie Azoulay, et al.
Summary:
A scholarly rebuttal to a prior publication, emphasizing the importance of timely and context-relevant data in intensive care research. The authors argue that reliance on outdated studies and improper data interpretation can introduce significant bias in clinical decision-making and policy formulation.

📌 4. Complement System Activation: Bridging Physiology, Pathophysiology, and Therapy

Journal: Intensive Care Medicine
Date: November 2024
DOI: 10.1007/s00134-024-07611-4
Authors: Elie Azoulay, Julien Zuber, Djillali Annane, et al.
Summary:
A comprehensive review of complement system activation in critically ill patients, exploring its dual role in host defense and inflammatory damage. The paper highlights novel therapeutic targets and the need for individualized modulation in conditions like sepsis and ARDS.

📌 5. Treatment of Invasive Pulmonary Aspergillosis and Candidiasis in ICU Patients

Journal: American Journal of Respiratory and Critical Care Medicine
Date: November 2024
DOI: 10.1164/rccm.202410-2045ST
Authors: Oleg Epelbaum, Elie Azoulay, et al.
Summary:
This ATS Clinical Practice Guideline outlines evidence-based recommendations for diagnosing and treating invasive fungal infections in ICU settings. It provides a framework for empirical and targeted antifungal therapy, addressing the rising concern of fungal superinfections in critical care.

Conclusion

Professor Elie Azoulay is an outstanding candidate for the Research for Hypothesis Achievement Award. His pioneering work in the intensive care management of immunocompromised patients, groundbreaking contributions to mental health in ICU survivors and their families, and leadership in multicenter, hypothesis-driven trials position him as a globally respected clinician-scientist. His profile aligns deeply with the intent of the award—translating complex hypotheses into high-impact, patient-centered outcomes.

Admasu Gizaw | Medicine and Health Sciences | Best Researcher Award

Posted on 31/01/202531/01/2025 by Research Hypothesis

Admasu Gizaw | Medicine and Health Sciences | Best Researcher Award

Mr Admasu Gizaw, Jimma University, Ethiopia

Admasu Gizaw, MScN, Ph.D. Fellow🎓🩺 is an esteemed nursing educator and researcher at Jimma University, Ethiopia. With an MSc in Adult Health Nursing (2010) and currently pursuing a Ph.D. in Nursing, his research focuses on patient-centered care and nursing standards. He has over 14 years of experience, serving as a lecturer, CPD officer, and program coordinator. His expertise spans mentorship, curriculum development, and systematic reviews. A dedicated contributor to national nursing policies, he has authored impactful studies on public health and nursing practice. Proficient in statistical software 📊, he actively advances Ethiopia’s healthcare education and nursing profession. 🚑📚

Publication Profile

Scopus

Education

Admasu Gizaw 🎓 is an experienced nursing professional specializing in Adult Health Nursing (Medical-Surgical Nursing). He earned his MScN from Jimma University in 2010, focusing on nurses’ intention to stay in the profession 🏥. Currently, he is a Ph.D. Fellow in Nursing at Jimma University (since 2023), researching person-centered nursing care and its outcomes in Ethiopian university hospitals 💡. His journey began with a BScN in Nursing from Jimma University (2004-2006) 🩺. With a strong academic and research background, he is dedicated to improving nursing care and fostering better healthcare environments in Ethiopia 🌍.

Experience

Admasu Gizaw is a dedicated nursing professional with extensive experience in surgical and academic settings 🏥👨‍⚕️. He began his career as a staff nurse in the operating theatre (2003-2004 E.C) before advancing to head nurse (2004-2005 E.C) and later serving as Vice Nursing Service Director at JUMC (2007-2008 E.C) 🌟. He also worked as Delegate Nursing Service Director (Dec-June 2008 E.C). With over nine years as a lecturer and Assistant Professor at Jimma University (since May 2016) 🎓, he coordinated the Operation Theatre Nursing Specialty Program (2017-2020) and currently serves as CPD Officer at Jimma University Institute of Health (since Feb 2023) 📚.

Certificate Awarded Training

Mr. Admasu Gizaw has made significant contributions to the nursing field in Ethiopia, particularly in course development and training. Notably, he has developed and trained courses on Safe Operation Theatre, Nursing Documentation and Reporting, Wound Care, Body Fluid Management, and Nursing Process Application for organizations like Jimma University, Ethiopian Nurses Association, and the Ministry of Health. His work includes the preparation of national nursing standards, undergraduate program guidelines, and licensure examination blueprints. Mr. Gizaw has also been involved in the development of nursing curricula and earned certificates of contribution and recognition from various prestigious institutions. 🎓🩺📚🇪🇹

Research Focus

Admasu Gizaw’s research primarily focuses on public health issues, particularly in low-resource settings. His studies examine global and regional health burdens, with specific attention to allergic disorders, meningitis, reproductive health, and chronic conditions like hypertension. He has contributed significantly to understanding the risk factors and prevalence of various diseases, including cancer and labor induction. His work also delves into the predictors of moral distress among healthcare workers and factors affecting health service utilization, especially in Ethiopian populations. Gizaw’s research aims to improve healthcare delivery and policy through evidence-based insights. 📊🌍🩺💉

Publication Top Notes

Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019

Global, regional, and national burden of meningitis and its aetiologies, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019

Predictors of Induction of Labor and Success Rate Among Mothers Giving Birth at Jimma University Medical Centre South West Ethiopia: Unmatched Case Control Study

Lifestyle modification practices and associated factors among hypertensive patients at Gambella Hospital Southwest Ethiopia; 2019

Predictors of moral distress among nurses working in Jimma University Medical Center, South West Ethiopia

Cancer Warning Symptoms Awareness and Associated Factors Among Individuals Living in Assella Town, Ethiopia

Reproductive health service utilization and associated factors among adolescents at public school in Adama Town east Shewa Ethiopia, 2018

Anne Vertigan | Medicine and Health Sciences | Best Researcher Award

Posted on 24/12/202424/12/2024 by Research Hypothesis

Anne Vertigan | Medicine and Health Sciences | Best Researcher Award

Assoc. Prof. Dr Anne Vertigan, John Hunter Hospital, Australia

Assoc. Prof. Dr. Anne Vertigan is an experienced Speech Pathologist with a career spanning over 30 years. She holds multiple degrees, including a PhD in chronic cough and airway hyperresponsiveness. Dr. Vertigan is the Director of Speech Pathology at Greater Newcastle Acute Hospital and has extensive experience in leadership and clinical roles. She has contributed significantly to research, focusing on chronic cough, laryngeal dysfunction, and asthma. Dr. Vertigan has been invited to speak at numerous international conferences and has received several prestigious grants. She is also an Associate Editor for the European Respiratory Journal. 📚🎤💬👩‍⚕️🌏

Publication Profile

Scopus

Education

Assoc. Prof. Dr. Anne Vertigan holds a B.App.Sc. (Speech Pathology) from La Trobe University (1991), an MBA from the University of Newcastle (2008), and a PhD from the University of Queensland, where she researched chronic cough and extrathoracic airway hyperresponsiveness syndrome, awarded in 2007. She also earned a Master in Clinical Epidemiology (2023) and a Master in Medical Statistics (2023) from the University of Newcastle. Dr. Vertigan’s academic and professional journey reflects her commitment to advancing knowledge in health, particularly in respiratory conditions and clinical research. 📚🎓💡🩺

Experience

Assoc. Prof. Dr. Anne Vertigan is a seasoned speech pathologist with an extensive career in healthcare leadership. She has served as the Director of Speech Pathology at the Greater Newcastle Acute Hospital Network since 2000. Previously, Dr. Vertigan was a Post-Doctoral Research Fellow at the NHMRC Centre for Clinical Excellence in Respiratory & Sleep Medicine (2008-2009). Her roles include District Profession Director of Speech Pathology at Hunter New England Health (2008-2015) and Director at John Hunter Hospital (1994-2000). With additional experience in various hospitals and community health centers, Dr. Vertigan has made significant contributions to speech pathology and healthcare. 🏥👩‍⚕️📚

Presentations

Assoc. Prof. Dr. Anne Vertigan is a renowned expert in laryngeal dysfunction, chronic cough, and voice disorders, delivering numerous invited talks at prestigious international conferences. In June 2024, she spoke at the Inducible Laryngeal Obstruction Conference in Pittsburgh, USA, on topics such as the hypersensitive larynx, laryngeal dysfunction, and the relationship between inducible laryngeal obstruction (ILO) and severe asthma. She also addressed dysphagia management and laryngeal hyperresponsiveness at the Phonosurgery Association of India in February 2024. Additionally, Dr. Vertigan shared her expertise at the French Society of ENT Congress and the ENT Head & Neck Instructional Course in Singapore. 🌍🎤👩‍⚕️

Grants

Assoc. Prof. Dr. Anne Vertigan has been awarded several prestigious grants and recognitions for her research in respiratory health. These include the $10,000 Ignite EMCR Equipment Grant (2018) for BioRadio Respiratory Inductive Plethysmography, and the $5,000 Strategic Research Pilot Grant (2020) to understand breathlessness in asthma. She also contributed to the $320,490.62 Medical Research Futures Fund on bushfire impact (2020), and the NHMRC’s $2.5 million CREATT Centre for asthma research (2020). In 2021, her work on non-pharmacological treatments for interstitial lung diseases won the SPP Robalo Cordeiro Award. Her latest project focuses on minimizing corticosteroid use in asthma. 🫁💡🌿

Research Focus

Assoc. Prof. Dr. Anne Vertigan’s research primarily focuses on respiratory diseases, particularly chronic cough, breathlessness, and asthma. She investigates the psychophysiological correlates of breathlessness and the impact of exposure to environmental factors like wildfire smoke. Dr. Vertigan also explores respiratory issues related to vocal cord dysfunction and laryngeal hypersensitivity. She is involved in studies aimed at improving diagnostic and therapeutic approaches for conditions such as chronic cough in children and adults. Her work aims to enhance understanding and management of airway conditions in clinical settings. 🌬️🫁👩‍⚕️🔬🌱

Publication top Notes

Abnormal breathing pattern features in chronic refractory cough

Understanding Breathlessness Burden and Psychophysiological Correlates in Asthma

Respiratory Diseases Associated With Wildfire Exposure in Outdoor Workers

Misconceptions on behavioral cough suppression therapy for pediatric nonspecific cough: A response to Weinberger and Buettner’s commentary on Fujiki et al.

Living With Asthma and Vocal Cord Dysfunction/Inducible Laryngeal Obstruction: “I Just Can’t Get Air In”

Cough in Children and Adults: Diagnosis, Assessment and Management (CICADA). Summary of an updated position statement on chronic cough in Australia

Antoinette Oot | Medicine and Health Sciences | Best Researcher Award

Posted on 05/08/202405/08/2024 by Research Hypothesis

Antoinette Oot | Medicine and Health Sciences | Best Researcher Award

Dr Antoinette Oot, NYU / NYC HHC Bellevue, United States

Based on the information provided, Antoinette Oot, MD, MPH, appears to be a strong candidate for a Best Researcher Award.

Publication profile

Scopus

Education

Antoinette Oot, MD, MPH, has a robust educational background that spans several prestigious institutions. She is currently a Fellow in Complex Family Planning at New York University/NYC Health + Hospitals Bellevue, a role she has held since July 2024. Previously, she served as the Administrative Chief Resident in the Department of Obstetrics and Gynecology at the same institution from 2020 to 2024. Dr. Oot earned her M.D./M.P.H. with honors from Northwestern University, Feinberg School of Medicine in 2020, and holds a B.Sc. in Chemistry with Honors from Brown University. Her early academic journey began at New York University, where she studied biochemistry. This educational trajectory demonstrates her commitment to both clinical excellence and public health, making her a strong candidate for the Best Researcher Award.

Work Experience & Post-Graduate Learning

Dr. Oot has accumulated significant work experience and engaged in continuous post-graduate learning, particularly in leadership and educational roles. As the Administrative Chief Resident at NYU, she optimized personnel coverage, facilitated communication, and promoted a fair work environment. She also served as the Resident OB/Gyn Clerkship Advisor, providing mentorship and improving medical education. Additionally, Dr. Oot has been an advocate for resident perspectives as a Class Representative on the Education Committee at NYU Langone Hospitals. Her experience extends to mentoring students and contributing to curricular development at Northwestern University. These roles highlight her dedication to improving medical education and her leadership skills, reinforcing her suitability for the Best Researcher Award.

Honors/Awards

Dr. Oot has received numerous honors and awards throughout her career, reflecting her outstanding contributions to the field of obstetrics and gynecology as well as public health. Notable awards include the 2023 Ryan Program Resident Award for Excellence in Family Planning and the 2022 Resident Recognition Award for Medical Student Education from NYU OB/GYN. She also received the Excellence in Public Health Award from the US Public Health Services in 2020 and was elected to the Gold Humanism Honor Society in 2019. These accolades underscore her exceptional research, clinical skills, and commitment to advancing women’s health, making her an exemplary candidate for the Best Researcher Award.

Presentations

Dr. Oot has actively participated in academic presentations, sharing her research findings at national conferences. In 2023, she delivered an oral presentation at the American Public Health Association Annual Meeting on increasing HIV pre-exposure prophylaxis among cisgender women. Her poster presentations at the Society of Gynecologic Surgeons and Society of Maternal-Fetal Medicine annual meetings further highlight her research involvement in women’s health and obstetric care. Her ability to present complex medical research to her peers indicates her leadership in the field and further supports her candidacy for the Best Researcher Award.

Publications

Dr. Oot has an impressive list of publications, contributing to various high-impact journals in the fields of obstetrics, gynecology, and public health. Her research spans a range of topics, including maternal morbidity, HIV prevention, and vaginal health, showcasing her broad expertise and commitment to improving patient outcomes. Notably, her recent work includes a mixed-methods evaluation of an HIV pre-exposure prophylaxis educational intervention published in AIDS Care and studies on maternal health in the Journal of Women’s Health. Her extensive publication record is a testament to her research capabilities, making her a strong candidate for the Best Researcher Award.

Personal Interests

Outside of her professional life, Dr. Oot enjoys baking, needlepoint, embroidery, and attending comics and art festivals. These hobbies provide a well-rounded perspective to her character, balancing her rigorous academic and professional pursuits with creative and relaxing activities. This personal insight into Dr. Oot’s life adds to her overall profile, showing her as a dedicated and multifaceted individual, further strengthening her candidacy for the Best Researcher Award.

Conclusion

Dr. Antoinette Oot’s extensive education, leadership in medical education, significant research contributions, and numerous awards position her as an outstanding candidate for the Best Researcher Award. Her dedication to advancing women’s health and public health, coupled with her personal commitment to mentorship and education, make her a deserving recipient of this recognition.

Research focus

The research focus of this individual centers on women’s health, obstetrics, and gynecology, with a particular emphasis on conditions affecting women such as genitourinary syndrome of menopause, maternal morbidity, and bacterial vaginosis. They also explore healthcare practices and policies, including interventions for HIV prevention and the evaluation of healthcare delivery in obstetric settings. Additionally, they investigate the use of electronic health records for analyzing maternal and neonatal complications, reflecting a commitment to improving health outcomes for women through research and healthcare policy reform. 🌸👩‍⚕️📊💊

Publication top notes

A randomized, pilot trial comparing vaginal hyaluronic acid to vaginal estrogen for the treatment of genitourinary syndrome of menopause

A mixed-methods evaluation of an HIV pre-exposure prophylaxis educational intervention for healthcare providers in a NYC safety-net hospital-based obstetrics and gynecology clinic

Association of Antenatal Housing Instability with Perinatal Care Utilization and Outcomes

Vaginal and Extra-Vaginal Bacterial Colonization and Risk for Incident Bacterial Vaginosis in a Population of Women Who Have Sex with Men

Management of Pelvic Organ Prolapse in the Adult Congenital Genitourinary Patient

Trends and Risk Markers for Severe Maternal Morbidity and Other Obstetric Complications

Genetic variation in toll-like receptor 5 and colonization with flagellated bacterial vaginosis-associated bacteria

Using Electronic Health Record and Administrative Data to Analyze Maternal and Neonatal Delivery Complications

Today’s Students, Tomorrow’s Physicians: Opinions on Enacted and Prospective Health Care Policies

Ahmed Ali | Medicine and Health Sciences | Best Researcher Award

Posted on 31/07/202431/07/2024 by Research Hypothesis

Ahmed Ali | Medicine and Health Sciences | Best Researcher Award

Dr Ahmed Ali, Beni-Suef University, Egypt

Based on Dr. Ahmed Ali’s extensive background in veterinary medicine, his significant contributions to vaccine development, and his active research in poultry diseases and vaccine efficacy, he appears to be a strong candidate for the Research for Best Researcher Award.

Publication profile

google scholar

Education and Training

Dr. Ali holds advanced degrees in Veterinary Medicine and Poultry Diseases from Beni-Suef University and The Ohio State University, showcasing a solid educational foundation in his field.

Research Contributions

His work includes leading the development of reverse genetics vaccines for avian influenza and Newcastle disease, and his involvement in live attenuated and inactivated vaccine research. This demonstrates a high level of expertise and impact in vaccine research and development.

Professional Experience

Dr. Ali has held various positions, from demonstrator to technical manager, and has been involved in significant roles related to vaccine R&D and quality control at MEVAC and the National Veterinary Vaccine Co. His roles highlight a career dedicated to advancing vaccine technologies and ensuring their quality and safety.

Publications

He has authored numerous research articles on vaccine safety, efficacy, and development, contributing valuable knowledge to the field. His research is published in reputable journals, reflecting the quality and relevance of his work.

Certifications and Skills

Dr. Ali’s certifications in biorisk management, strategic planning, and Six Sigma further demonstrate his commitment to excellence and continuous improvement in his field.

Field Achievements

His leadership in developing innovative vaccines and ensuring compliance with international standards underscores his significant contributions to veterinary science.

Publication top notes

Swine influenza H1N1 virus induces acute inflammatory immune responses in pig lungs: a potential animal model for human H1N1 influenza virus

Prevalence of avian respiratory viruses in broiler flocks in Egypt

Experimental co-infection of infectious bronchitis and low pathogenic avian influenza H9N2 viruses in commercial broiler chickens

Identification of swine H1N2/pandemic H1N1 reassortant influenza virus in pigs, United States

Pandemic and seasonal human influenza virus infections in domestic cats: prevalence, association with respiratory disease, and seasonality patterns

Molecular characterization of Newcastle disease virus (genotype VII) from broiler chickens in Egypt

Co-infections, genetic, and antigenic relatedness of avian influenza H5N8 and H5N1 viruses in domestic and wild birds in Egypt

Protective efficacy of different live attenuated infectious bronchitis virus vaccination regimes against challenge with IBV variant-2 circulating in the Middle East

The emergence, evolution and spread of infectious bronchitis virus genotype GI-23

Rajendra Rohokale | Medicine and Health Sciences | Best Researcher Award

Posted on 29/07/202429/07/2024 by Research Hypothesis

Rajendra Rohokale | Medicine and Health Sciences | Best Researcher Award

Dr Rajendra Rohokale, University of Florida, United States

Dr. Rajendra Rohokale is a Research Scientist at the University of Florida, specializing in Synthetic Organic Chemistry, Carbohydrate Chemistry, and Glycochemistry. With a Ph.D. from Savitribai Phule Pune University, his notable projects include synthesizing complex carbohydrates for therapeutic applications and developing fully synthetic cancer vaccines. Dr. Rohokale’s work has led to significant advancements in glycoimmunology and drug delivery. An experienced researcher and reviewer for prestigious journals, he has over 360 citations on Google Scholar and holds an Orchid ID: orcid.org/0000-0001-8083-0466. 🌟🧪🔬📚

Publication profile

Orcid

Education

🎓 From 2010 to 2017, Rajendra Rohokale pursued a Ph.D. in Organic Chemistry at the Department of Chemistry, Savitribai Phule Pune University, Pune, India, under the guidance of Prof. Dilip D. Dhavale (F.A.Sc, F.N.A.Sc.). Their thesis was titled “Chiron Approach Towards the Syntheses of Amino Acids, Piperidine, Azepane, Polyhydroxylated Pyrrolizidine Alkaloids and Activation of Diazo-Ketones Using Visible Light Photoredox Catalysis and Dye.” [Name] earned their Master of Science (Organic Chemistry) (First Class) from the same university in 2009 and completed their Bachelor of Science (Chemistry) (First Class with Distinction) from New Arts, Science, and Commerce College, Ahmednagar in 2007. 📚🔬

Experience

🧪 Since August 2023, I’ve been a Research Scientist at the University of Florida, Gainesville. From January 2019 to August 2023, I was a Post-doctoral Research Associate at the same institution. My work focuses on synthesizing complex carbohydrates and their conjugates for therapeutic applications, including the development of glycosphingolipids (GSLs) and monophosphoryl lipid-A derivatives as cancer vaccine carriers. I specialize in synthetic organic and carbohydrate chemistry, creating efficient methods for synthesizing oligosaccharides and glycoconjugates. My research aims to advance cancer immunotherapy and glycoimmunology, with significant contributions to medical science. 💊🧫🔬

Presentations

He have actively participated in numerous esteemed conferences, including the Florida Heterocyclic Conference 2022 (FloHet 2022) at the University of Florida in March 2022 and the ChemPhotoChem-EJOC joint virtual symposium on Photoreact Catalysis in December 2021. He also attended FloHet 2020 at the University of Florida in March 2020. He presented a talk at the National Conference on “Bioinspired Materials in Science” at New Arts College, Pune, India, in January 2018. Additionally, He participated in the Satellite Meeting on Frontiers in the Chemistry & Biology of Oligosaccharides in January 2014 and attended various other international conferences from 2009 to 2013. 🌟🔬🌍📚

Research focus

Dr. Rajendra Rohokale’s research focuses on the synthesis and functional analysis of glycosphingolipids (GSLs) and their interactions in cell membranes. His work spans developing bifunctional GSL probes for studying GSL-interacting proteins, creating novel vaccine adjuvants, and exploring bacterial polysaccharide-based antibacterial conjugate vaccines. He also delves into advanced chemical synthesis techniques for GSLs and their derivatives, utilizing methods like diastereoselective cycloaddition and chemoenzymatic synthesis. Dr. Rohokale’s contributions significantly impact medicinal chemistry, organic chemistry, and infectious disease research. 🧪🔬💉

Publication top notes

Bifunctional glycosphingolipid (GSL) probes to investigate GSL-interacting proteins in cell membranes

Diastereoselective 1,3-Dipolar Intramolecular Nitrone Olefin Cycloaddition (INOC) Reaction of a Sugar-derived Allyl Alcohol: Synthesis of Functionalized Aminocyclopentitols.

Monophosphoryl Lipid A-Rhamnose Conjugates as a New Class of Vaccine Adjuvants

Development in the Concept of Bacterial Polysaccharide Repeating Unit-Based Antibacterial Conjugate Vaccines

Structural characterization and analysis of different epimers of neutral glycosphingolipid LcGg4 by ion mobility spectrometry-mass spectrometry

A Diversity-Oriented Strategy for Chemical Synthesis of Glycosphingolipids: Synthesis of Glycosphingolipid LcGg4 and Its Analogues and Derivatives

Iridium(III)-Catalyzed Alkynylation of 2-(Hetero)arylquinazolin-4-one Scaffolds via C–H Bond Activation

Eosin y photoredox catalyzed net redox neutral reaction for regiospecific annulation to 3-sulfonylindoles: Via anion oxidation of sodium sulfinate salts

Metal-Free Synthesis of 3-Thiocyanatobenzothiophenes by Eosin Y Photoredox-Catalyzed Cascade Radical Annulation of 2-Alkynylthioanisoles

Visible-Light-Mediated Eosin Y Photoredox-Catalyzed Vicinal Thioamination of Alkynes: Radical Cascade Annulation Strategy for 2-Substituted-3-sulfenylindoles

Gulali Aktas | Medicine and Health Sciences | Best Researcher Award

Posted on 01/07/202401/07/2024 by Research Hypothesis

Gulali Aktas | Medicine and Health Sciences | Best Researcher Award

Prof Dr Gulali Aktas, Abant Izzet Baysal University Hospital, Turkey

Prof. Dr. Gulali Aktas is a dedicated physician with 24 years of experience in internal medicine. As an academician for 13 years, he has mentored countless medical students and contributed to significant research. He holds an MD and Associate Professorship from Abant Izzet Baysal University. His prolific work includes 183 international journal publications, 19 conference presentations, and 11 book chapters. Recognized for his excellence, he was nominated for the Raise the Line Faculty Award in 2022 and is listed in Stanford University’s top 2% scientists. Fluent in Turkish, English, and basic German, he champions patient-centered care and lifelong learning. 🏥📚🌟

Publication profile

google scholar

Education

Dr. Gulali Aktas is an Associate Professor of Internal Medicine since 2015. They completed their Internal Medicine residency (PhD equivalent) at Ondokuz Mayis University, Samsun, Turkey (2003-2008), and Pulmonology residency at Yedikule Training and Research Hospital, Istanbul, Turkey (2002-2003). They earned their MD from Ondokuz Mayis University in 2000. With 211 research contributions published in peer-reviewed journals and an impressive H-index of 35 (WoS), 42 (Google Scholar), and 36 (Scopus), Dr. Gulali Aktas is a prominent researcher. Fluent in Turkish, English, and basic German, they are known for their honesty, hard work, optimism, and foresight. 🌟📚🩺🌍

Experience

From 2011 to 2014, courses such as Dyspnea and Edema, Approach to Chest Pain, Fever and Hyperthermia, and Leukopenia and Leukocytosis were taught in the spring, while Chronic Leukemia, Aplastic Anemia and Myelodysplasia, and Principles of Blood Transfusion were covered in the autumn. Rheumatology topics like Anamnesis, Physical Examination, and Laboratory Test Analysis were emphasized. Other subjects included Familial Mediterranean Fever, Behcet’s Disease, Chronic Pancreatitis, Liver Cirrhosis, Esophageal Diseases, Colon Polyps, Celiac Disease, Chronic Viral and Non-Viral Hepatitis, and Mesenteric Ischemia. 🩺📚✨

Presentations

Dr. Gulali Aktaş has presented several notable studies. At the 30th World Congress of Endourology in 2012, his team discussed “Warfarin intoxication induced bilateral renal hematoma” (📚🩸). He compared surgical techniques for pylonidal sinus surgery and explored sleep quality in IBS patients at the XVI Annual European Society of Surgery (🔪💤). In 2013, at the 50th ERA-EDTA Congress, he highlighted the effects of nocturnal blood pressure on hemodialysis patients’ nutrition (🌙🩺). His research on metabolic syndrome, presented at the 10th Metabolic Syndrome Symposium, investigated platelet volume, epicardial adipose tissue, and non-alcoholic hepatosteatosis (🩸📈). At the 51st ERA-EDTA Congress, he examined atrial conduction in hemodialysis patients (❤️🩺).

Research focus

G Aktas focuses on the use of hematological and biochemical markers as diagnostic and prognostic tools in various medical conditions. His research includes studies on the neutrophil-to-lymphocyte ratio as an indicator for diabetic control in type 2 diabetes mellitus and Hashimoto’s thyroiditis. He also explores the predictive value of the uric acid to HDL cholesterol ratio for metabolic syndrome and diabetes control, as well as novel inflammatory markers derived from hemogram parameters in irritable bowel syndrome and COVID-19. His work aims to improve diagnostic accuracy and patient outcomes. 🩸🔬📊

Publication top notes

Neutrophil to lymphocyte ratio as an indicative of diabetic control level in type 2 diabetes mellitus

Elevated neutrophil-to-lymphocyte ratio in the diagnosis of Hashimoto’s thyroiditis

Uric acid to HDL cholesterol ratio is a strong predictor of diabetic control in men with type 2 diabetes mellitus

Does neutrophil-to-lymphocyte ratio predict active ulcerative colitis?

Serum uric acid to HDL-cholesterol ratio is a strong predictor of metabolic syndrome in type 2 diabetes mellitus

Diabetes control could through platelet-to-lymphocyte ratio in hemograms

Irritable bowel syndrome is associated with novel inflammatory markers derived from hemogram parameters

Could red cell distribution width be a marker in Hashimoto’s thyroiditis?

Association between novel inflammatory markers derived from hemogram indices and metabolic parameters in type 2 diabetic men

Hematological predictors of novel Coronavirus infection

Muritala Suleiman Odidi | Medicine and Health Sciences | Best Researcher Award

Posted on 18/06/202418/06/2024 by Research Hypothesis

Muritala Suleiman Odidi | Medicine and Health Sciences | Best Researcher Award

Dr Muritala Suleiman Odidi, Federal University Dutse Jigawa State, Nigeria

Dr. Muritala Suleiman Odidi is a dedicated lecturer at Kogi State University, Anyigba, Nigeria, specializing in gross anatomy, embryology, genetics, biostatistics, and anthropology since June 2018 📚. He uses audio-visual microscopy to enhance histology teaching 🧬. Before academia, he was a Business Development Executive at Emzor Pharmaceutical Industries (2015-2018) and a Senior Medical Sales Representative at Nosak Health Care Limited (2012-2015) 💊. He has attended numerous workshops and conferences globally, contributed to many publications, and holds several administrative roles within his department 🏅. His research focuses on forensic science and anthropometry 🔬.

Publication profile

google scholar

Education

He hold a PhD in Human Anatomy from Ahmadu Bello University, Zaria, Kaduna, conferred on December 16th, 2022 🎓. Prior to this, He completed my MSc in Human Anatomy and Physical Anthropology at Bayero University, Kano, Nigeria, on March 30th, 2016 📚. My academic journey began with a BSc in Human Anatomy from Ahmadu Bello University, Zaria, Kaduna, where I graduated with a second class upper on April 16th, 2009 🎓. This robust educational foundation has equipped me with extensive knowledge and expertise in the field of human anatomy and physical anthropology 🧠.

Experience

Since June 2018, he have been a lecturer, teaching and demonstrating gross anatomy, embryology, genetics, biostatistics, and anthropology to undergraduate medical students. Additionally, he utilize audio-visual microscopy to effectively teach histology 📚. Previously, from March 2015 to June 2018, he worked as a Business Development Executive at Emzor Pharmaceutical Industries Limited in Lagos, Nigeria. In this role, he organized and conducted Continuing Medical Education on the company’s product ranges, brokered business deals with health institutions, and interfaced with Key Opinion Leaders (KOL) 💼. Prior to that, from February 2012 to February 2015, I served as a Senior Medical Sales Representative at Nosak Health Care Limited, where he promoted new products and increased brand awareness during community pharmacist meetings and conferences 🌟.

Awards

He was honored to serve as a Fellow in the Data Science Fellowship Program by the Bureau of Statistics, Kaduna State Government, in collaboration with the Bill and Melinda Gates Foundation (BMGF) from January to July 2021 📊. During this enriching experience, he honed my data science skills and contributed to impactful projects 🎯. Additionally, he received a prestigious prize and Certificate of Honour for meritorious services from the Government of Oyo State of Nigeria, in collaboration with the National Youth Service Corps 🏅. This recognition underscores my dedication and hard work in service to my community and nation 🌟.

Research focus

Based on the provided publication list, M.O. Suleiman’s research focus spans multiple disciplines including forensic science, entomology, anatomy, and toxicology. Their work covers the use of plant-based substances for pest control, the effects of plant extracts on health, and various aspects of human morphology and forensic analysis. This diversity indicates a multidisciplinary approach with significant contributions to both environmental and health sciences.